Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children

NCT01564290 — Phase 4, Completed, 54 participants, Centro Pediatrico Albina de Patino

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children: A Randomized Double-blind Trial

RegistryNCT01564290
StatusCompleted
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: quadruple, treatment
Enrollment54 (Actual)
SponsorCentro Pediatrico Albina de Patino (Other)
ConditionsAcute Diarrhea, Acute Gastroenteritis
InterventionsProbiotic yogurt, Placebo probiotic (Dietary supplement, drug)
Datesstart 2011-02-01, primary completion 2011-08-01, completion 2012-02-01, first posted 2012-03-27, last updated 2012-03-27
Locations1 site in Bolivia

Related Papers Related Patents Related Grants Related Experts
All trials for Acute Diarrhea All trials for Acute Gastroenteritis All trials of Probiotic yogurt All trials of Placebo probiotic

-Summary

The purpose of this study is to determine the effect of probiotic yogurt in acute watery diarrhea in children. The investigators will compare the effect of two different probiotics products.

Expand all sections  ·  Collapse all

+Detailed description

Background: Acute Gastroenteritis is one of the most and frequent disease in the childhood, considering the advances in treatment, Lactobacillus Rahmnosus has being well described as a probiotic who reduces the number of days of hospitalization and also de the severity.

Objectives: To evaluate the effect of the probiotic yogurt in the treatment of children who are between 10 months and 3 years old with acute non-dysenteric diarrhea.

Methods: A randomized clinical trial, controlled, double-blind. The investigators will have two groups of patients : One group will receive Lactobacillus Rahmnosus in a yogurt presentation and the other one will receive Sacharomyces boulardii in a lyophilized form ; the parameters of evaluation are going to be the number of diarrhea stools by day, number of vomiting episodes, hours with fever, nutritional and immunization state.

+Arms and interventions

ArmTypeInterventionsDescription
probioticPlacebo comparatorDrug: Placebo probioticProbiotic product with Sacharomices Boulardii
probiotic yogurtActive comparatorDietary Supplement: Probiotic yogurtYogurt with Lactobacilus Rhamnonsus strain spp
  • Probiotic yogurt (Dietary supplement): Lactobacilus Rhamnonsus 100000000 UFC per mL. Dosage 50 mL twice daily fo 5 days.
  • Placebo probiotic (Drug), also known as Florestor: Lyophilized probiotic, containing 250 mg per sachet dosage to about 2 times a day for 5 days.

+Outcome measures

Primary outcomes

  • Duration of diarrhea [five days]: participants will be followed for the duration of hospital stay, an expected average of 5 days

Secondary outcomes

  • Duration of fever [five days]: participants will be followed for the duration of hospital stay, an expected average of 5 days
  • duration of vomiting [five days]: participants will be followed for the duration of hospital stay, an expected average of 5 days
  • duration of hospitalization [five days]: participants will be followed for the duration of hospital stay, an expected average of 5 days

+Eligibility

Sex: All, ages: 10 Months to 36 Months

Inclusion Criteria:

* All acute diarrhea

Exclusion Criteria:

* Severe malnourishment
* Severe dehydration
* Systemic infections

+Locations (1)

FacilityCityCountryStatus
Centro Pediatrico Albina PatinoCochabamba, CochabambaBolivia

+Investigators